Editors: Manuela Oliveira, Isa Serrano

Series Title: Frontiers in Antimicrobial Agents

The challenges of antibiotic resistance in the development of new therapeutics

Volume 1

eBook: US $99 Special Offer (PDF + Printed Copy): US $168
Printed Copy: US $119
Library License: US $396
ISSN: 2452-2570 (Print)
ISSN: 2452-2589 (Online)
ISBN: 978-1-68108-141-0 (Print)
ISBN: 978-1-68108-140-3 (Online)
Year of Publication: 2015
DOI: 10.2174/97816810814031150101

Introduction

The addition of only two novel classes of antibiotics to fight drug resistant microorganisms in the clinic over the past three decades means that the quest for new molecules that are effective against the threat of drug resistance is now a significant issue in modern medicine. Researchers have begun to experiment on alternative therapies to combat this threat.

Novel chemical agents are considered to be drugs of choice for tomorrow's clinical practice owing to their low probability to generate resistance. The first volume of Frontiers in Antimicrobial Agents describes innovative alternatives to the classical antimicrobial therapeutics, such as phage therapy, AMPs, probiotics, novel biocides, natural products and immunotherapy. Cutting-edge research is brought to the forefront, shedding light on the developments taking place to meet the challenge of drug resistant microorganisms. The volume also features information on antimicrobial approaches in veterinary medicine.

The book is a useful reference for researchers, microbiologists and healthcare professionals interested in updates on antibiotic resistance and alternatives to classical antibiotic therapy.

Foreword

- Pp. i
João João Mendes
Download Free

Preface

- Pp. ii-iii (2)
Manuela Oliveira, Isa Serrano
Download Free

List of Contributors

- Pp. iv-v (2)
Manuela Oliveira, Isa Serrano
Download Free

Introduction

- Pp. 3-9 (7)
Manuela Oliveira, Amélia Fernandes, Isa Serrano
View Abstract

Bacteriophages as Antibacterial Agents: Why are We Facing an Antibiotic Crisis and How Could Bacteriophages be of Help?

- Pp. 10-32 (23)
Jean-Paul Pirnay, Gilbert Verbeken, Mario Vaneechoutte, Serge Jennes, Maya Merabishvili, Isa Serrano, Daniel De Vos
View Abstract

Antimicrobial Peptides

- Pp. 33-68 (36)
Isa Domingues Serrano
View Abstract

Probiotics: Ways of Action and Beneficial Effects

- Pp. 69-96 (28)
Nabil Benomar, Hikmate Abriouel, Rubén Pérez Pulido, Leyre Lavilla Lerma, María del Carmen Casado Muñoz, Antonio Gálvez
View Abstract

Immunotherapy

- Pp. 97-148 (52)
Solange Gil, Dias J., Lourenço A.M., Leal R., Tavares L.
View Abstract

Perspectives on Natural Products

- Pp. 149-177 (29)
Ana Patrícia Quendera, Teresa Semedo-Lemsaddek
View Abstract

Bacteriocins

- Pp. 178-207 (30)
Sara Correia Santos, Manuela Oliveira, Teresa Semedo Lemsaddek
View Abstract

Biocides – A Reasonable Alternative to Prevent and Control Microorganisms?

- Pp. 208-233 (26)
Rui Seixas, Carla Mottola
View Abstract

Novel Therapeutic Strategies in Veterinary Medicine

- Pp. 234-260 (27)
Ana Duarte, Luis Tavares
View Abstract

Summary

- Pp. 261-262 (2)
Manuela Oliveira, Isa Serrano
Download Free

Subject Index

- Pp. 263-266 (4)
Manuela Oliveira, Isa Serrano
Download Free

RELATED BOOKS

.An Update on SARS-CoV-2: Damage-response Framework, Potential Therapeutic Avenues and the Impact of Nanotechnology on COVID-19 Therapy.
.COVID-19: Effects in Comorbidities and Special Populations.
.Current Developments in the Detection and Control of Multi Drug Resistance.
.Moving From COVID-19 Mathematical Models to Vaccine Design: Theory, Practice and Experiences.